Tag | Content |
---|
EnhancerAtlas ID | HS047-35857 |
Organism | Homo sapiens |
Tissue/cell | Fetal_placenta |
Coordinate | chrX:152772640-152773500 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
CTCF | MA0139.1 | chrX:152773164-152773183 | GTGCGCCCTCTAGTGGCCA | - | 7.82 | KLF16 | MA0741.1 | chrX:152773448-152773459 | GCCCCGCCCCC | + | 6.02 | KLF5 | MA0599.1 | chrX:152773448-152773458 | GCCCCGCCCC | + | 6.02 | SP2 | MA0516.2 | chrX:152773444-152773461 | CCCAGCCCCGCCCCCAC | + | 6.37 | SP4 | MA0685.1 | chrX:152773445-152773462 | CCAGCCCCGCCCCCACA | + | 6.02 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_01772 | chrX:152771574-152773013 | Aorta | SE_01772 | chrX:152773221-152774208 | Aorta |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH0XI153506 | chrX | 152771575 | 152773013 | GH0XI153507 | chrX | 152773081 | 152773230 |
|
Enhancer Sequence | CAGGTGAGAG CTGGGCATGC ACAGCCAGGT TCCCTAAGGC TGGGCTGGGG GAGGCGTGTG 60 TGTCCCCGGG CAGTCCCTCA GTCCCCTGGC CCTCCTTCCC GACCGGCTCT GGGCATCTGC 120 AAGGGAGCGG TCCTGATGCT CCCAGCTGGT GCTGAGGAGG CAGGGAGCAG GGGCTCCATG 180 GTGGATACCG AGCAAGGCAG CCTGGTAGCT CTTGGACCCG AGGGTCTCCA GGTGGGTCGG 240 ACACCAGAAA GATGTGGCAG AGTCCAGGGA GTCGAGAAAC TGTGGGCGTG GGAGTGCACA 300 GATCTGTGCC AAGACAGTGA CCGCCCAGGG CAGGAAGTAG GCTGACGAGG GGGAGCAGGG 360 TCTTGCCTGG GATTCTATCG GGAGCTTCCA TCCCTGGCCT GGCCCGCAAC CAGGTGGGTG 420 ATCTTGGTCT TGCCCAGCCC TGCTCCATCC ACAAGTGTTT GGAGCACCCC CATCCGCACC 480 AGCTGCGAGC CAGCACCGCG CAGGCCATGC CCATGCTGGG CCGAGTGCGC CCTCTAGTGG 540 CCATTGTCAT GTTCACCAGC ACTGGGCTCC CAGCCCAACC CAGCAGGCGC CTCGCCTGCC 600 CACCTCCGCT CCTCCCAGAG ACAGCAAGAC GGTGGCTCCA GAGAGTTGGA GGGGCTGCTA 660 GAGGGCGAGC TCCTCTGCTG ACTGGAAGAA AGAGGAGGGC ATCCCAAGGG CTCTTTCTCC 720 TCTCATGCCC CATGGAGTGT GAGGGTGCTC CCCCGAGGCT CAGGCCACCT TTCCTCCACC 780 TCACACCACC AAACACACCT CTACCCCAGC CCCGCCCCCA CATGTCCTCA ACCTGACCCA 840 CCTGAGACCC TCATCCTTGT 860
|